as on February 27, 2026 at 7:59 am IST
Day's Low
Day's High
6.03%
Downside
1.51%
Upside
52 Week's Low
52 Week's High
66.83%
Downside
77.64%
Upside
Check Caribou Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$182.3M
EPS (TTM)
-1.5943
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.54
Industry PE ratio
-2.6784410646387835
PEG Ratio
0EBITDA
-135.7M
Revenue (TTM)
9.3M
Profit Margin
0.00%
Return On Equity TTM
-74.28%
Track how Caribou Biosciences P/E has moved over time to understand its valuation trends.
Caribou Biosciences in the last 5 years
Lowest (-6.17x)
September 30, 2022
Industry (-2.68x)
February 27, 2026
Today (-1.54x)
February 27, 2026
Highest (-0.55x)
June 30, 2025
Today’s Price to Earnings Ratio: -1.54x
Compare market cap, revenue, PE, and other key metrics of Caribou Biosciences with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $182.3M | NA | -1.54 | 0.00% | |
| BUY | $43.4B | 123.66% | 141.1 | 8.45% | |
| BUY | $122.7B | 125.89% | 31.55 | 32.94% | |
| NA | $39.0B | NA | 664.59 | 1.38% | |
| BUY | $82.9B | 71.07% | 18.9 | 31.41% |
The Caribou Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Caribou Biosciences investment value today
Current value as on today
₹1,75,865
Returns
₹75,865
(+75.86%)
Returns from Caribou Biosciences Stock
₹71,552 (+71.55%)
Dollar Returns*
₹4,313 (+4.31%)
Based on 15 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Caribou Biosciences. Average target price of $10.88
Get share price movements and forecasts by analysts on Caribou Biosciences.
What analysts predicted
81.71%UPSIDE
Target Price
$10.88
Current Price
$1.99
Analyzed by
15 Analysts
Target
$10.88
Caribou Biosciences target price $10.88, a slight upside of 81.71% compared to current price of $1.99. According to 15 analysts rating.
Search interest for Caribou Biosciences Stock has increased by 160% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:160% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -54.09M → -27.54M (in $), with an average increase of 96.4% per quarter
Price Rise
![]()
In the last 7 days, CRBU stock has moved up by 8.3%
Best in 1 Year
![]()
In the last 1 year, CRBU has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 139.7%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 2.66M → 2.19M (in $), with an average decrease of 17.6% per quarter
| Organisation | Caribou Biosciences |
| Headquarters | 2929 7th Street, Berkeley, CA, United States, 94710 |
| Industry | Services |
| CEO | Dr. Rachel E. Haurwitz Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Daniel Poon | Vice President of Operations & Information Technology |
Ms. Ruhi A. Khan M.B.A. | Chief Business Officer |
Dr. Tina Albertson M.D., Ph.D. | Chief Medical Officer |
Mr. Timothy P. Kelly M.B.A. | Chief Technology Officer |
Ms. Barbara G. McClung Esq., J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Ryan Fischesser | Interim Principal Accounting Officer & Controller |
Ms. Amy Figueroa C.F.A. | Vice President of Investor Relations & Corporate Communications |
Ms. Reigin Zawadzki | Chief People Officer |
Dr. Rachel E. Haurwitz Ph.D. | Co-Founder, CEO, President & Director |
Mr. Sriram Ryali M.B.A. | Chief Financial Officer |
Caribou Biosciences share price today is $1.99 as on at the close of the market. Caribou Biosciences share today touched a day high of $2.02 and a low of $1.87.
Caribou Biosciences share touched a 52 week high of $3.54 on and a 52 week low of $0.66 on . Caribou Biosciences stock price today i.e. is closed at $1.99,which is 43.71% down from its 52 week high and 201.52% up from its 52 week low.
Caribou Biosciences market capitalisation is $0.00T as on .
Indian investors can start investing in Caribou Biosciences (CRBU) shares with as little as ₹90.899 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹908.99 in Caribou Biosciences stock (as per the Rupee-Dollar exchange rate as on ).
Based on Caribou Biosciences share’s latest price of $1.99 as on February 27, 2026 at 2:29 am IST, you will get 5.0251 shares of Caribou Biosciences. Learn more about
fractional shares .